A detailed history of Northwest & Ethical Investments L.P. transactions in Incyte Corp stock. As of the latest transaction made, Northwest & Ethical Investments L.P. holds 14,944 shares of INCY stock, worth $1.07 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
14,944
Previous 30,764 51.42%
Holding current value
$1.07 Million
Previous $2.03 Billion 49.24%
% of portfolio
0.03%
Previous 0.05%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 11, 2025

SELL
$65.08 - $83.38 $1.03 Million - $1.32 Million
-15,820 Reduced 51.42%
14,944 $1.03 Billion
Q3 2024

Nov 13, 2024

SELL
$57.33 - $68.61 $370,466 - $443,357
-6,462 Reduced 17.36%
30,764 $2.03 Billion
Q2 2024

Aug 14, 2024

BUY
$51.18 - $63.75 $1.91 Million - $2.37 Million
37,226 New
37,226 $2.26 Billion

Others Institutions Holding INCY

About INCYTE CORP


  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $15.9B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track Northwest & Ethical Investments L.P. Portfolio

Follow Northwest & Ethical Investments L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northwest & Ethical Investments L.P., based on Form 13F filings with the SEC.

News

Stay updated on Northwest & Ethical Investments L.P. with notifications on news.